Skip to main content
. 2016 Sep 7;6:32725. doi: 10.1038/srep32725

Figure 2. One novel anti-TB drug agent, bis-biguanide dihydrochloride (BBD).

Figure 2

(A) Structure and Chemical Abstracts Service (CAS) number of BBD. (B) CFU counting results of MSL-infected THP-1 and A549 cells treated by DMSO and BBD (20 μM) for 12 hours, respectively.